1. Home
  2. XYLO vs EVOK Comparison

XYLO vs EVOK Comparison

Compare XYLO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • EVOK
  • Stock Information
  • Founded
  • XYLO 1999
  • EVOK 2007
  • Country
  • XYLO Israel
  • EVOK United States
  • Employees
  • XYLO N/A
  • EVOK N/A
  • Industry
  • XYLO
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYLO
  • EVOK Health Care
  • Exchange
  • XYLO NYSE
  • EVOK Nasdaq
  • Market Cap
  • XYLO 3.8M
  • EVOK 4.2M
  • IPO Year
  • XYLO N/A
  • EVOK 2013
  • Fundamental
  • Price
  • XYLO $4.84
  • EVOK $2.95
  • Analyst Decision
  • XYLO
  • EVOK
  • Analyst Count
  • XYLO 0
  • EVOK 0
  • Target Price
  • XYLO N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • XYLO 1.5K
  • EVOK 14.3K
  • Earning Date
  • XYLO 06-17-2025
  • EVOK 05-13-2025
  • Dividend Yield
  • XYLO N/A
  • EVOK N/A
  • EPS Growth
  • XYLO N/A
  • EVOK N/A
  • EPS
  • XYLO N/A
  • EVOK N/A
  • Revenue
  • XYLO $29,858,000.00
  • EVOK $11,594,083.00
  • Revenue This Year
  • XYLO $279.19
  • EVOK $57.82
  • Revenue Next Year
  • XYLO N/A
  • EVOK $59.12
  • P/E Ratio
  • XYLO N/A
  • EVOK N/A
  • Revenue Growth
  • XYLO N/A
  • EVOK 89.89
  • 52 Week Low
  • XYLO $2.70
  • EVOK $1.94
  • 52 Week High
  • XYLO $6.67
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 41.82
  • EVOK 38.86
  • Support Level
  • XYLO $4.79
  • EVOK $3.33
  • Resistance Level
  • XYLO $5.26
  • EVOK $3.66
  • Average True Range (ATR)
  • XYLO 0.12
  • EVOK 0.29
  • MACD
  • XYLO -0.04
  • EVOK -0.06
  • Stochastic Oscillator
  • XYLO 10.20
  • EVOK 2.99

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: